Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR)

Historical Holders from Q1 2023 to Q3 2025

Symbol
GPCR on Nasdaq
Type / Class
Equity / Ordinary Shares, $0.0001 par value
Shares outstanding
173M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
56.6M
Holdings value
$1.58B
% of all portfolios
0.005%
Grand Portfolio weight change
+0%
Number of holders
155
Number of buys
78
Number of sells
-85
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLINGTON MANAGEMENT GROUP LLP 11.9% +20% $578M $99.8M 20.6M +20.9% Wellington Management Group LLP 31 Oct 2025
FMR LLC 11.6% $374M 19.9M FMR LLC 30 Jun 2025
Avoro Capital Advisors LLC 9.38% $454M 16.2M Avoro Capital Advisors LLC 30 Sep 2025
Deep Track Capital, LP 7.32% -17.8% $354M -$77.1M 12.6M -17.9% Deep Track Capital, LP 30 Sep 2025
BIOTECHNOLOGY VALUE FUND L P 5.6% $171M 9.61M BVF PARTNERS L P/IL 11 Aug 2025
Capital Research Global Investors 3.8% $168M 6.49M Capital Research Global Investors 31 Mar 2025
JANUS HENDERSON GROUP PLC 7.7% -3.75% $125M -$3.48M 4.45M -2.72% JANUS HENDERSON GROUP PLC 30 Sep 2025

Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 56.6M $1.58B +$86.6M $28.00 155
2025 Q2 54.7M $1.13B -$13M $20.74 172
2025 Q1 55.9M $981M -$97.5M $17.31 150
2024 Q4 60.7M $1.65B -$124M $27.12 162
2024 Q3 61.4M $2.69B +$109M $43.89 160
2024 Q2 59.3M $2.33B +$610M $39.27 164
2024 Q1 43.6M $1.86B +$49.2M $42.86 119
2023 Q4 42.6M $1.74B +$365M $40.76 121
2023 Q3 32.8M $1.64B +$750M $50.42 83
2023 Q2 17.6M $699M +$106M $41.57 48
2023 Q1 14.4M $343M +$343M $23.79 38